These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32040814)

  • 1. Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Fujikawa H; Ide S; Yamamoto A; Omura Y; Yin C; Kusunoki K; Kusunoki Y; Yasuda H; Yokoe T; Hiro J; Ohi M; Kusunoki M
    J Gastrointest Surg; 2021 Feb; 25(2):492-502. PubMed ID: 32040814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.
    Nishi M; Shimada M; Tokunaga T; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Wada Y; Eto S; Yoshimoto T
    World J Surg Oncol; 2021 Jul; 19(1):201. PubMed ID: 34229704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.
    Sung S; Son SH; Park EY; Kay CS
    PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Pretreatment: Lymphocyte-to-Monocyte Ratio in Patients With Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Yamamoto A; Toiyama Y; Okugawa Y; Oki S; Ide S; Saigusa S; Araki T; Kusunoki M
    Dis Colon Rectum; 2019 Feb; 62(2):171-180. PubMed ID: 30451750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    World J Surg; 2017 Mar; 41(3):876-883. PubMed ID: 27730348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Oki S; Ide S; Yamamoto A; Ichikawa T; Kitajima T; Fujikawa H; Yasuda H; Saigusa S; Hiro J; Yoshiyama S; Kobayashi M; Araki T; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):998-1007. PubMed ID: 29786882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Toiyama Y; Oki S; Okugawa Y; Ide S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Inoue Y; Araki T; Kusunoki M
    Oncology; 2018; 95(5):270-280. PubMed ID: 29996133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
    Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
    Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy.
    Ide S; Toiyama Y; Okugawa Y; Shimura T; Fujikawa H; Hiro J; Ohi M; Kusunoki M
    Int J Clin Oncol; 2021 Apr; 26(4):708-716. PubMed ID: 33415573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
    Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative carcinoembryonic antigen level has a prognostic value for distant metastasis and survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery: a retrospective multi-institutional analysis.
    Jeong S; Nam TK; Jeong JU; Kim SH; Kim K; Jang HS; Jeong BK; Lee JH
    Clin Exp Metastasis; 2016 Dec; 33(8):809-816. PubMed ID: 27553616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Yamamoto A; Toiyama Y; Okugawa Y; Saigusa S; Ide S; Fujikawa H; Hiro J; Yasuda H; Yoshiyama S; Ohi M; Araki T; Kusunoki M
    Oncology; 2019; 96(2):70-78. PubMed ID: 30227430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.